Open House "Online Psychotherapy"
GWQ ServicePlus AG, DüsseldorfTED 344331-2026
value not stated1 lot, 2 years
Mon 29 May12:00 in Berlin
578days
Public tenders in Germany
945 open tenders
CountryTenderValueClosesDays left
Contract for the Supply of Dressings under § 31 Subsection 1a of the German Social Code Book V (SGB V)
AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 302193-2026
value not stated1 lot
Wed 31 May12:00 in Berlin
580days
Open-House Contracts for Association Supplies 2026-2028
AOK Bremen/BremerhavenTED 372585-2026
value not stated1 lot
Wed 31 May23:59 in Berlin
580days
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) (open-house model)
AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 408239-2026
value not stated2 lots
Thu 1 Jun12:00 in Berlin
581days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Omalizumab, ATC L04AG08, for the period 01.08.2026 - 31.07.2028
DAK-Gesundheit, HamburgTED 406825-2026
€11 lot, 2 years
Mon 5 Jun12:00 in Berlin
585days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Abaloparatid, ATC H05AA04 for the period 01.08.2026 - 31.07.2028
DAK-Gesundheit, HamburgTED 410478-2026
€11 lot, 2 years
Mon 5 Jun12:00 in Berlin
585days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Peginterferon alfa-2a, ATC L03AB11, for the period 01.08.2026 - 31.07.2028
DAK-Gesundheit, HamburgTED 412634-2026
€11 lot, 2 years
Mon 5 Jun12:00 in Berlin
585days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Tocilizumab (exclusively in the form of PEN and FER), ATC L04AC07 for the period 01.08.2026 - 31.07.2028
DAK-Gesundheit, HamburgTED 410091-2026
€11 lot, 2 years
Mon 5 Jun12:00 in Berlin
585days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Budesonide (FAM Kinpeygo and interchangeable medicines), ATC A07EA06 for the period 01.08.2026 - 31.07.2028
DAK-Gesundheit, HamburgTED 411639-2026
€11 lot, 2 years
Mon 5 Jun12:00 in Berlin
585days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Naloxegol, ATC A06AH03 for the period 01.08.2026 - 31.07.2028
DAK-Gesundheit, HamburgTED 407721-2026
€11 lot, 2 years
Mon 5 Jun12:00 in Berlin
585days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance umeclidinium + vilanterol, ATC R03AL03, for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 491386-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active substance Brolucizumab, ATC code S01LA06, for the period from 01.09.2026 to 31.08.2028
DAK-Gesundheit, HamburgTED 493642-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Tacrolimus, ATC L04AD02 for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 492492-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Emtricitabine + Rilpivirine + Tenofovir disoproxil fumarate, ATC J05AR08 for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 491642-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Ranibizumab, ATC S01LA04, for the period 01.09.2026 – 31.08.2028
DAK-Gesundheit, HamburgTED 493717-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Triptorelin, ATC L02AE04 for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 491708-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Abatacept, ATC L04AA24 for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 493555-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance natalizumab (only dosage form ILO), ATC L04AA23, for the period 01.09.2026 - 31.08.2028
DAK-Gesundheit, HamburgTED 491013-2026
€11 lot, 2 years
Wed 5 Jul12:00 in Berlin
615days
Open House Procedure for Collective Means
AOK Rheinland/Hamburg - Die Gesundheitskasse, DüsseldorfTED 372695-2026
value not stated1 lot, 2 years
Mon 31 Jul12:00 in Berlin
641days
Conclusion of a non-exclusive framework agreement for Inspection Audits, Preliminary Investigations and Further Building Technical Investigations in the Open-House Procedure 2026 ff.
Die Autobahn GmbH des Bundes - NL Südwest, StuttgartTED 519231-2026
value not stated1 lot, 2 years
Mon 31 Jul23:59 in Berlin
641days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.